Penicillamine-induced dermatomyositis From Dr G A C Major Royal Newcastle Hospital Newcastle, NSW, Australia Dear Sir, I read with interest the report by Dr Wojnarowska (December 1980 Journal, p 884) of a case of 'Dermatomyositis induced by penicillamine'.
Whilst, within the text of the article, the author quite correctly stops short of claiming a definite cause and effect relationship, the implication is nevertheless there. I do not feel that such an implication is warranted.
Given that myositis is a recognized association of rheumatoid arthritis (RA) and that in widely accepted classifications of dermato/polyrnyositis, the muscle disease occurring in association with other connective tissue diseases such as RA forms one of the major groupings (Rose & Walton 1966 , Bohan et al. 1977 , it is hardly surprising that the use of a therapeutic agent will coincide with the development of a 'natural association' of the primary disease.
The case of a patient, who recently came under my care is illustrative in this regard. A 52-year-old Caucasian male was referred by his local doctor for management of severe, long-standing RA, which had undergone an acute flare up in the preceding four months. Assessment in the clinic confirmed classical RA (ARA criteria) with widespread active synovitis. There was no clinical suggestion of proximal myopathy or rash. The serum creatinine phosphokinase (CPK) was normal. Partly because of a history of poor compliance with drug treatment, it was decided to treat with physiotherapy and non-steroidal antiinflammatory drugs alone. Indomethacin was recommended, with arrangements for a follow-up clinic visit two weeks hence, when it was planned to review the case with a view to the possible use of penicillamine. The patient defaulted on his appointment, and was not seen again for another six weeks, when he was admitted to hospital as an emergency because of profound muscle weakness and pain. The clinical findings were those of typical polymyositis superimposed on longstanding RA. The CPK on admission was greater than 7000 VII and the serum aldolase 137 VII (normal range 20-105 and 1-12 VII respectively). Subsequent EMG and muscle biopsy helped to confirm the clinical diagnosis. He was treated with high-dose prednisolone and azathioprine, and after a difficult early period the condition was brought under satisfactory control.
Had this patient not defaulted on his follow-up appointment, there is every likelihood that because of his severe RA he would have been started on penicillamine, and thus become the potential subject of an 'adverse drug reaction' report to this drug. As it was, his only drug exposure was to indomethacin.
As a final point it is worth noting that the complications of penicillamine referred to by Dr Wojnarowska, such as phemphigus etc., differ significantly from dermatomyositis in that they, unlike dermatomyositis, all have an established association with specific humoral autoantibodies, both in the native disease as well as in the instances where they arise in association with penicillamine therapy.
Though the finding of the sacrolemmal basement membrane IgG is of potential interest, unfortunately there is insufficient detail provided in the report to allow assessment of its significance. , p 840) is salutary and timely. He points out that there are great differences of opinion among experienced otosurgeons. Some reports have reflected unbounded enthusiasm for complex reconstructive techniques with canal well preservation in a variety of bone necrotizing lesions including not only cholesteatoma, but also in tympanosclerosis, cholesterol granuloma, and varying combinations of these diseases. All kinds of metal and plastic prostheses have been used, frequently in combination. As pointed out by Smith, some surgeons have courageously reported their bad results with such mechanistic techniques, but others have not.
The first objective of tympanoplastic surgery should obviously be the removal of the lesion. Preoperative and operative considerations must include (I) the nature of the histological lesion per se .. (2) its precise intra temporal bone location; (3) the accompanying loss of function, including the conductive or sensorineural hearing status and vestibular status; and last but not least (4) preoperative laboratory findings -bacteriological and radiological.
No one procedure, open or closed, can be advocated without consideration of these four 'L' factors: lesion, location, loss of function, and laboratory findings.
